[Deresinated naphthalan in the treatment of psoriatic arthritis].

Abstract

The paper presents pathogenetic validation for introduction of naphthalane oil as a therapeutic modality in psoriatic arthritis. The criteria of the inflammation activity are specified. As a result of deresinified naphthalane treatment, 43 psoriatic patients exhibited positive trends in clinical and laboratory manifestations of the inflammation, reduced intensity of the disease, declined articular and skin syndromes. The response persisted for 6 months.

• Authors: V D Grigor'eva, N G Badalov
• Journal: Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury (Vopr Kurortol Fizioter Lech Fiz Kult) 1994 Jul-Aug Issue 4 Pg. 13-5 ISSN: 0042-8787 [Print] Russia (Federation)
• Vernacular Title: Obessmolennyĭ naftalan v lechenii psoriaticheskogo artrita.
• PMID: 7846875 (Publication Type: Comparative Study, English Abstract, Journal Article)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Naphthalenes
• Ointments
• naphthalan

Topics

• Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
• Arthritis, Psoriatic (drug therapy)
• Chronic Disease
• Drug Evaluation
• Humans
• Naphthalenes (therapeutic use)
• Ointments
• Remission Induction
• Time Factors